Loading ...

Proleukin and Rapamune in Type 1 Diabetes

(

IL2-RAPA

)

ITN Protocol #:

ITN018AI

Branded Name:

IL2-RAPA

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Phase I Trial of Proleukin and Rapamune in Recent-onset Type 1 Diabetes Mellitus

Clinical Operations Manager

NIAID Project Manager

Rho Scientist

Study Personnel:

Protocol Chair

Carla Greenbaum, MD cgreenbaum@benaroyaresearch.org

Work:

206-342-6933

Protocol Chair

Carol Soppe csoppe@immunetolerance.org

Work:

415-353-4879

Protocol Chair

Wendy Gao gaowe@mail.nih.gov

Work:

240-627-3471

Admin Links

Shortcuts

ITN Documents

Links